Select Publications
Journal articles
2024, 'Understanding stigma and attitudes towards hepatitis B among university students in Australia of Chinese and Vietnamese background', BMC Public Health, 24, http://dx.doi.org/10.1186/s12889-024-20226-0
,2024, 'Applying a stigma and time framework to facilitate equitable access to hepatitis C care among women who inject drugs: The ETHOS Engage Study', International Journal of Drug Policy, 129, http://dx.doi.org/10.1016/j.drugpo.2024.104477
,2024, 'The ‘missing’ in the ‘endgame’ of hepatitis C elimination: A qualitative study in New South Wales, Australia', Drug and Alcohol Review, 43, pp. 1256 - 1263, http://dx.doi.org/10.1111/dar.13845
,2024, '‘There's too much power in this number. It's freaking the whole response out’: The views of key informants on evidence and targets to achieve hepatitis C elimination goals in Australia', Journal of Viral Hepatitis, 31, pp. 59 - 65, http://dx.doi.org/10.1111/jvh.13896
,2024, '‘People Like Us Would Have No Clue If the Information Is Online’: Exploring Understanding and Sources of Hepatitis B Information Among Vietnamese Australians', Journal of Racial and Ethnic Health Disparities, http://dx.doi.org/10.1007/s40615-024-02055-4
,2024, 'The time of cure: hepatitis C treatment and the matter of reinfection among people who inject drugs', Health Sociology Review, 33, pp. 104 - 118, http://dx.doi.org/10.1080/14461242.2024.2315031
,2023, 'Lives Worth Grieving: Differential Coverage of Overdose Deaths in Australian News Media (2015–2020)', Contemporary Drug Problems, 50, pp. 361 - 380, http://dx.doi.org/10.1177/00914509231178937
,2023, 'Practising care in a pandemic: Accounting for everyday life during COVID-19 among people who inject drugs', Sociology of Health and Illness, 45, pp. 791 - 809, http://dx.doi.org/10.1111/1467-9566.13612
,2023, 'Perceptions of COVID-19 Vaccines: Lessons from Selected Populations Who Experience Discrimination in the Australian Healthcare System', Health and Social Care in the Community, 2023, pp. 1 - 10, http://dx.doi.org/10.1155/2023/5901128
,2022, 'Health worker perceptions of the impact of COVID-19 on harm reduction services for people who inject drugs', Health and Social Care in the Community, 30, pp. 2320 - 2329, http://dx.doi.org/10.1111/hsc.13782
,2022, 'What is known about the care and support provided for an ageing population with lived experience of chronic viral hepatitis as they near end-of-life: A scoping review', Health and Social Care in the Community, 30, pp. e3775 - e3788, http://dx.doi.org/10.1111/hsc.14066
,2022, '“You need a designated officer” – Recommendations from correctional and justice health personnel for scaling up hepatitis C treatment-as-prevention in the prison setting', International Journal of Drug Policy, 106, http://dx.doi.org/10.1016/j.drugpo.2022.103746
,2022, 'Establishing the impact of consumer participation in alcohol and other drug treatment settings in Australia', Health and Social Care in the Community, 30, pp. e1183 - e1193, http://dx.doi.org/10.1111/hsc.13525
,2022, '‘Not just one box that you tick off’ – Deconstructing the hepatitis C care cascade in the interferon-free direct acting antiviral era from the client perspective', International Journal of Drug Policy, 102, http://dx.doi.org/10.1016/j.drugpo.2022.103610
,2021, 'Considering treatment-as-prevention scale-up for Australian prisons: a qualitative sub-study of expert stakeholders from the Australian ‘surveillance and treatment of prisoners with hepatitis C’ project (SToP-C)', Harm Reduction Journal, 18, pp. 46, http://dx.doi.org/10.1186/s12954-021-00494-4
,2021, 'Hepatitis C treatment as prevention in the prison setting: Assessments of acceptability of treatment scale up efforts by prison correctional and health personnel', International Journal of Drug Policy, 98, http://dx.doi.org/10.1016/j.drugpo.2021.103379
,2021, 'Expert stakeholder perspectives on the acceptability of treatment-as-prevention in prison: a qualitative substudy of the ‘Surveillance and Treatment of Prisoners with Hepatitis C’ project (SToP-C)', Addiction, 116, pp. 2761 - 2769, http://dx.doi.org/10.1111/add.15477
,2021, 'The role of social capital in facilitating hepatitis C treatment scale-up within a treatment-as-prevention trial in the male prison setting', Addiction, 116, pp. 1162 - 1171, http://dx.doi.org/10.1111/add.15277
,2021, 'Pharmaceutical citizenship in an era of universal access to hepatitis C treatment: Situated potentials and limits', Health: an interdisciplinary journal for the social study of health, illness and medicine, http://dx.doi.org/10.1177/1363459320988887
,2020, '“Towards eliminating viral hepatitis”: Examining the productive capacity and constitutive effects of global policy on hepatitis C elimination', International Journal of Drug Policy, 80, http://dx.doi.org/10.1016/j.drugpo.2019.02.008
,2020, '‘Behind closed doors, no one sees, no one knows’: hepatitis C, stigma and treatment-as-prevention in prison', Critical Public Health, 30, pp. 130 - 140, http://dx.doi.org/10.1080/09581596.2018.1541225
,2020, 'Perceptions and concerns of hepatitis C reinfection following prison-wide treatment scale-up: Counterpublic health amid hepatitis C treatment as prevention efforts in the prison setting', International Journal of Drug Policy, 77, http://dx.doi.org/10.1016/j.drugpo.2020.102693
,2020, 'Police decision-making with young offenders: Examining barriers to the use of diversion options', Australian and New Zealand Journal of Criminology, 53, pp. 137 - 154, http://dx.doi.org/10.1177/0004865819879736
,2019, '‘Fighting a losing battle’: prisoners’ perspectives of treatment as prevention for hepatitis C with inadequate primary prevention measures', Drugs: Education, Prevention and Policy, 26, pp. 502 - 507, http://dx.doi.org/10.1080/09687637.2018.1494135
,2019, 'Making sense of ‘side effects’: Counterpublic health in the era of direct-acting antivirals', International Journal of Drug Policy, 72, pp. 77 - 83, http://dx.doi.org/10.1016/j.drugpo.2019.06.002
,2019, 'How ‘Vulnerable’ young people describe their interactions with police: building positive pathways to drug diversion and treatment in Sydney and Melbourne, Australia', Police Practice and Research, 20, pp. 18 - 33, http://dx.doi.org/10.1080/15614263.2017.1347787
,2018, 'Understanding facilitators and barriers of direct-acting antiviral therapy for hepatitis C virus infection in prison', Journal of Viral Hepatitis, 25, pp. 1526 - 1532, http://dx.doi.org/10.1111/jvh.12987
,2018, 'A policy analysis exploring hepatitis C risk, prevention, testing, treatment and reinfection within Australia's prisons', Harm Reduction Journal, 15, pp. 39, http://dx.doi.org/10.1186/s12954-018-0246-6
,2018, 'Providing a model of health care service to stimulant users in Sydney', Drugs: Education, Prevention and Policy, 25, pp. 130 - 137, http://dx.doi.org/10.1080/09687637.2016.1221061
,2018, 'Who goes first? Understanding hepatitis C risk among injecting networks in the prison setting', Drug and Alcohol Dependence, 183, pp. 96 - 101, http://dx.doi.org/10.1016/j.drugalcdep.2017.10.030
,2017, '‘Affording’ new approaches to couples who inject drugs: A novel fitpack design for hepatitis C prevention', International Journal of Drug Policy, 50, pp. 19 - 35, http://dx.doi.org/10.1016/j.drugpo.2017.07.001
,2017, '“Why Am I the Way I Am?” Narrative Work in the Context of Stigmatized Identities', Qualitative Health Research, 27, pp. 2222 - 2232, http://dx.doi.org/10.1177/1049732317728915
,2017, 'The intimate relationship as a site of social protection: Partnerships between people who inject drugs', Social Science and Medicine, 180, pp. 125 - 134, http://dx.doi.org/10.1016/j.socscimed.2017.03.012
,2017, '“Don't think I'm going to leave you over it”: Accounts of changing hepatitis C status among couples who inject drugs', Drug and Alcohol Dependence, 173, pp. 78 - 84, http://dx.doi.org/10.1016/j.drugalcdep.2016.12.020
,2016, 'Harm reduction workers and the challenge of engaging couples who inject drugs in hepatitis C prevention', Drug and Alcohol Dependence, 168, pp. 170 - 175, http://dx.doi.org/10.1016/j.drugalcdep.2016.09.010
,2016, 'Practices of partnership: Negotiated safety among couples who inject drugs', Health: An Interdisciplinary Journal for the Social Study of Health, Illness and Medicine, http://dx.doi.org/10.1177/1363459316660859
,2016, 'Hepatitis C prevention and convenience: why do people who inject drugs in sexual partnerships ‘run out’ of sterile equipment?', Critical Public Health, 26, pp. 294 - 306, http://dx.doi.org/10.1080/09581596.2015.1036839
,2016, 'Understanding decisions made about hepatitis C treatment by couples who inject drugs', Journal of Viral Hepatitis, 23, pp. 89 - 95, http://dx.doi.org/10.1111/jvh.12451
,2016, 'Trust and people who inject drugs: The perspectives of clients and staff of Needle Syringe Programs', International Journal of Drug Policy, 27, pp. 138 - 145, http://dx.doi.org/10.1016/j.drugpo.2015.08.018
,2015, 'POLICING AND PATHWAYS TO DIVERSION AND CARE AMONG VULNERABLE YOUNG PEOPLE WHO HAVE SUBSTANCE USE ISSUES', DRUG AND ALCOHOL REVIEW, 34, pp. 31 - 31, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000367694000084&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
,2015, 'Evaluation of two community-controlled peer support services for assessment and treatment of hepatitis C virus infection in opioid substitution treatment clinics: The ETHOS study, Australia', International Journal of Drug Policy, 26, pp. 992 - 998, http://dx.doi.org/10.1016/j.drugpo.2015.01.005
,2015, 'Hepatitis C prevention and convenience: why do people who inject drugs in sexual partnerships ‘run out’ of sterile equipment?', Critical Public Health, http://dx.doi.org/10.1080/09581596.2015.1036839
,2014, 'Trust and people who inject drugs: The perspectives of clients and staff of Needle Syringe Programs', International Journal of Drug Policy, http://dx.doi.org/10.1016/j.drugpo.2015.08.018
,2014, 'Barriers and facilitators for assessment and treatment of hepatitis C virus infection in the opioid substitution treatment setting: Insights from the ETHOS study', Journal of Viral Hepatitis, 21, pp. 560 - 567, http://dx.doi.org/10.1111/jvh.12183
,2014, ''Not just Methadone Tracy': Transformations in service-user identity following the introduction of hepatitis C treatment into Australian opiate substitution settings', Addiction, 109, pp. 452 - 459, http://dx.doi.org/10.1111/add.12392
,2014, ''We are people too': Consumer participation and the potential transformation of therapeutic relations within drug treatment', International Journal of Drug Policy, http://dx.doi.org/10.1016/j.drugpo.2014.05.002
,2014, 'How to build trustworthy hepatitis C services in an opioid treatment clinic? A qualitative study of clients and health workers in a co-located setting', International Journal of Drug Policy, 25, pp. 865 - 870, http://dx.doi.org/10.1016/j.drugpo.2014.01.011
,2013, 'Client and staff experiences of a co-located service for hepatitis C care in opioid substitution treatment settings in New South Wales, Australia', Drug and Alcohol Dependence, 133, pp. 529 - 534, http://dx.doi.org/10.1016/j.drugalcdep.2013.07.023
,2013, 'NEW INSIGHTS INTO HEPATITIS C TRANSMISSION', DRUG AND ALCOHOL REVIEW, 32, pp. 17 - 17, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000326649400056&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
,2013, 'Understanding barriers to hepatitis c virus care and stigmatization from a social perspective', Clinical Infectious Diseases, 57, http://dx.doi.org/10.1093/cid/cit263
,